Correlation Engine 2.0
Clear Search sequence regions


  • behavior (1)
  • berlin (1)
  • bladder (1)
  • boston (1)
  • cp 99, 994 (1)
  • dermal (1)
  • direct (1)
  • gr159897 (1)
  • Lys5 (12)
  • neurokinin (2)
  • Neurokinin 1 (2)
  • Neurokinin 2 (2)
  • NK1Rs (7)
  • NK2Rs (8)
  • NKR (2)
  • period (1)
  • rapid (3)
  • rats (4)
  • receptors neurokinin- 1 (2)
  • receptors neurokinin- 2 (2)
  • smooth muscle (1)
  • Sizes of these terms reflect their relevance to your search.

    Neurokinin 2 receptor (NK2R) agonists may be useful for treating bladder and bowel dysfunction via direct contraction of detrusor and gastrointestinal smooth muscle. The NK2R agonist [Lys5, MeLeu9, Nle10]-NKA(4-10) (LMN-NKA) induces urination and defecation, but also produces the potential side effect of dermal flushing in rats. Although LMN-NKA is a NK2R agonist, it also has affinity for neurokinin 1 receptors (NK1R). Therefore, the goal of this study was to determine the neurokinin receptor (NKR) subtypes responsible for LMN-NKA-induced urination, defecation, and flushing by blocking either NK2Rs or NK1Rs before LMN-NKA administration. To accomplish this goal, we developed a simple high-throughput 'rapid detection voiding assay' to detect rapid-onset drug-induced urination and defecation in rats. In LMN-NKA dose-response experiments, LMN-NKA (10-100 μg/kg, subcutaneous) was injected and urination, defecation, and flushing were monitored for 30 min. For NKR antagonist experiments, vehicle, the NK2R antagonist GR159897, or the NK1R antagonist CP-99,994 were injected before an acclimation period. Following acclimation, saline or 100 μg/kg LMN-NKA were injected, and behavior was observed for 30 min. LMN-NKA produced dose-related increases in urination, defecation, and flushing. Blocking NK2Rs reduced urination and blocked defecation, without affecting flushing. Blocking NK1Rs did not change LMN-NKA-induced urination or defecation but reduced LMN-NKA-induced flushing. Using the rapid detection voiding assay we show that LMN-NKA-induced urination and defecation are mediated by NK2Rs, while flushing is mediated by NK1Rs. Therefore, drugs that are more selective for NK2 vs. NK1Rs should produce rapid-onset urination and defecation without producing the potential side effect of flushing. © 2022 Walter de Gruyter GmbH, Berlin/Boston.

    Citation

    Jason B Cook, Raymond Piatt, Lesley Marson. Lys5,MeLeu9,Nle10]-NKA(4-10) induces neurokinin 2 receptor mediated urination and defecation and neurokinin 1 receptor mediated flushing in rats: measured using the rapid detection voiding assay. Journal of basic and clinical physiology and pharmacology. 2023 Mar 01;34(2):227-233

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36377965

    View Full Text